Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.’s MMR Vaccine in Healthy Children 12 to 15 Months of Age
Condition(s):Measles; Mumps; Rubella; Measles-Mumps-Rubella VaccineLast Updated:January 7, 2021Completed